Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


GUIDELINE TITLE

Diagnosis and management of headache.

BIBLIOGRAPHIC SOURCE(S)

  • Singapore Ministry of Health. Diagnosis and management of headache. Singapore: Singapore Ministry of Health; 2007 Sep. 104 p. [374 references]

REFERENCES SUPPORTING THE RECOMMENDATIONS

  • Adelman LC, Adelman JU, Von Seggern R, Mannix LK. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting. Headache 2000 Jul-Aug;40(7):572-80. PubMed


  • Adly C, Straumanis J, Chesson A. Fluoxetine prophylaxis of migraine. Headache 1992 Feb;32(2):101-4. PubMed


  • Ahuja GK, Verma AK. Propranolol in prophylaxis of migraine. Indian J Med Res 1985 Sep;82:263-5. PubMed


  • Akpunonu BE, Mutgi AB, Federman DJ, Volinsky FG, Brickman K, Davis RL, Gilbert C, Asgharnejad M. Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study [published erratum appears in Ann Emerg Med 1995 Jun;25(6):857]. Ann Emerg Med 1995 Apr;25(4):464-9. PubMed


  • al Deeb SM, Biary N, Bahou Y, al Jaberi M, Khoja W. Flunarizine in migraine: a double-blind placebo-controlled study (in a Saudi population). Headache 1992 Oct;32(9):461-2. PubMed


  • American Academy of Pediatrics Committee on Drugs: The transfer of drugs and other chemicals into human milk. Pediatrics 1994 Jan;93(1):137-50. PubMed


  • Amery WK, Waelkens J. Prevention of the last chance: an alternative pharmacologic treatment of migraine. Headache 1983 Jan;23(1):37-8. PubMed


  • Andersson PG, Dahl S, Hansen JH, Hansen PE, Hedman C, Kristensen TN, de Fine Olivarius B. Prophylactic treatment of classical and non-classical migraine with metoprolol--a comparison with placebo. Cephalalgia 1983 Dec;3(4):207-12. PubMed


  • Arthur GP, Hornabrook RW. The treatment of migraine with BC 105 (pizotifen): a double blind trial. N Z Med J 1971 Jan;73(464):5-9. PubMed


  • Aube M. Migraine in pregnancy. Neurology 1999;53(4 Suppl 1):S26-8. [16 references] PubMed


  • Bates D, Ashford E, Dawson R, Ensink FB, Gilhus NE, Olesen J, Pilgrim AJ, Shevlin P. Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group. Neurology 1994 Sep;44(9):1587-92. PubMed


  • Bellavance AJ, Meloche JP. A comparative study of naproxen sodium, pizotyline and placebo in migraine prophylaxis. Headache 1990 Nov;30(11):710-5. PubMed


  • Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996 Sep;61(3):285-90. PubMed


  • Benson MD, Rebar RW. Relationship of migraine headache and stroke to oral contraceptive use. J Reprod Med 1986 Dec;31(12):1082-8. [47 references] PubMed


  • Borgesen SE, Nielsen JL, Moller CE. Prophylactic treatment of migraine with propranolol. A clinical trial. Acta Neurol Scand 1974;50(5):651-6. PubMed


  • Boureau F, Joubert JM, Lasserre V, Prum B, Delecoeuillerie G. Double-blind comparison of an acetaminophen 400 mg-codeine 25 mg combination versus aspirin 1000 mg and placebo in acute migraine attack. Cephalalgia 1994 Apr;14(2):156-61. PubMed


  • Bousser MG, D'Allens H, Richard A. Efficacy of subcutaneous sumatriptan in the acute treatment of early- morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group. J Intern Med 1993 Aug;234(2):211-6. PubMed


  • Bousser MG, Massiou H. Migraine in the reproductive cycle. In: Olesen J, Tfelt-Hansen P, Welch KM, editor(s). The headaches. New York (NY): Raven Press; 1993. p. 413-9.


  • Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D, MIGR-002 Study Group. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004 Feb 25;291(8):965-73. PubMed


  • Bussone G, Diener HC, Pfeil J, Schwalen S. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract 2005 Aug;59(8):961-8. PubMed


  • Cady RC, Ryan R, Jhingran P, O'Quinn S, Pait DG. Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial . Arch Intern Med 1998 May 11;158(9):1013-8. PubMed


  • Cady RK, Dexter J, Sargent JD, Markley H, Osterhaus JT, Webster CJ. Efficacy of subcutaneous sumatriptan in repeated episodes of migraine [published erratum appears in Neurology 1993 Oct;43(10):2010]. Neurology 1993 Jul;43(7):1363-8. PubMed


  • Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, Skaggs H Jr. Treatment of acute migraine with subcutaneous sumatriptan. JAMA 1991 Jun 5;265(21):2831-5. PubMed


  • Campistol J, Campos J, Casas C, Herranz JL. Topiramate in the prophylactic treatment of migraine in children. J Child Neurol 2005 Mar;20(3):251-3. PubMed


  • Carroll JD, Maclay WP. Pizotifen (BC 105) in migraine prophylaxis. Curr Med Res Opin 1975;3(2):68-71. PubMed


  • Cerbo R, Barbanti P, Fabbrini G, Pascali MP, Catarci T. Amitriptyline is effective in chronic but not in episodic tension-type headache: pathogenetic implications. Headache 1998 Jun;38(6):453-7. PubMed


  • Chilson CN, Brown SJ. Role of botulinum toxin type A in the prophylactic treatment of migraine headaches. Ann Pharmacother 2005 Dec;39(12):2081-5. PubMed


  • Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988;8(Suppl 7):1-96. PubMed


  • Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med 1995 Nov;26(5):541-6. PubMed


  • Couch JR, Hassanein RS. Amitriptyline in migraine prophylaxis. Arch Neurol 1979 Nov;36(11):695-9. PubMed


  • Couch JR, Hassanein RS. Migraine and depression: effect of amitriptyline prophylaxis. Trans Am Neurol Assoc 1976;101:234-7. PubMed


  • Cuetter AC, Aita JF. CT scanning in classic migraine. Headache 1983 Jul;23(4):195. PubMed


  • Cull RE. Investigation of late-onset migraine. Scott Med J 1995 Apr;40(2):50-2. PubMed


  • Cutler N, Mushet GR, Davis R, Clements B, Whitcher L. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths. Neurology 1995 Aug;45(8 Suppl 7):S5-9. PubMed


  • Cutler NR, Claghorn J, Sramek JJ, Block G, Panebianco D, Cheng H, Olah TV, Reines SA. Pilot study of MK-462 in migraine. Cephalalgia 1996 Apr;16(2):113-6. PubMed


  • D'Amico D, Grazzi L, Usai S, Moschiano F, Bussone G. Topiramate in migraine prophylaxis. Neurol Sci 2005 May;26 Suppl 2:s130-3. [19 references] PubMed


  • Dahlof C, Bjorkman R. Diclofenac-K (50 and 100 mg) and placebo in the acute treatment of migraine. Cephalalgia 1993 Apr;13(2):117-23. PubMed


  • Dahlof C. No clearcut longterm prophylactic effect of one month of treatment with propranolol in migraineurs. Cephalalgia 1987;7(Suppl 6):459-60.


  • Dahlof CG, Jacobs LD. Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headache. Cephalalgia 1996 Apr;16(2):117-23. PubMed


  • Damen L, Bruijn JK, Verhagen AP, Berger MY, Passchier J, Koes BW. Symptomatic treatment of migraine in children: a systematic review of medication trials. Pediatrics 2005 Aug;116(2):e295-302. [22 references] PubMed


  • De Benedittis G, Lorenzetti A, Sina C, Bernasconi V. Magnetic resonance imaging in migraine and tension-type headache. Headache 1995 May;35(5):264-8. PubMed


  • de Lignieres B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG. Prevention of menstrual migraine by percutaneous oestradiol. Br Med J (Clin Res Ed) 1986 Dec 13;293(6561):1540. PubMed


  • De Weerdt CJ, Bootsma HP, Hendriks H. Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine 1996;3:225-30.


  • Del Bene E, Poggioni M, Garagiola U, Maresca V. Intramuscular treatment of migraine attacks using diclofenac sodium: a crossover clinical trial. J Int Med Res 1987 Jan-Feb;15(1):44-8. PubMed


  • Demirkaya S, Vural O, Dora B, Topcuoglu MA. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache 2001 Feb;41(2):171-7. PubMed


  • Dennerstein L, Morse C, Burrows G, Oats J, Brown J, Smith M. Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol 1988 Jun;2(2):113-20. PubMed


  • Di Trapani G, Mei D, Marra C, Mazza S, Capuano A. Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study. Clin Ter 2000 May-Jun;151(3):145-8. PubMed


  • Diamond S, Balm TK, Freitag FG. Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther 2000 Sep;68(3):312-9. PubMed


  • Diamond S, Baltes BJ. Chronic tension headache--treated with amitriptyline--a double-blind study. Headache 1971 Oct;11(3):110-6. PubMed


  • Diamond S, Freitag FG. A double-blind trial of flunarizine in migraine prophylaxis. Headache Q 1993;4(2):169-72.


  • Diamond S. Ibuprofen versus aspirin and placebo in the treatment of muscle contraction headache. Headache 1983 Sep;23(5):206-10. PubMed


  • Diener HC, Dahlof CG. Headache associated with chronic use of substances. In: Olesen J, Tfelt-Hansen P, Welch KM, editor(s). The headaches. 2nd ed. Philadelphia (PA): Lippincott Williams and Wilkins; 1999. p. 871-8.


  • Diener HC, Jansen JP, Reches A, Pascual J, Pitei D, Steiner TJ, Eletriptan and Cafergot Comparative Study Group. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison. Eur Neurol 2002;47(2):99-107. PubMed


  • Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group. Cephalalgia 2005 Oct;25(10):776-87. PubMed


  • Diener HC, Rahlfs VW, Danesch U. The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol 2004;51(2):89-97. PubMed


  • Diener HC, Tfelt-Hansen P, Dahlof C, Lainez MJ, Sandrini G, Wang SJ, Neto W, Vijapurkar U, Doyle A, Jacobs D, MIGR-003 Study Group. Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004 Aug;251(8):943-50. PubMed


  • Diener HC. Eletriptan in migraine. Expert Rev Neurother 2005 Jan;5(1):43-53. [61 references] PubMed


  • Ellis GL, Delaney J, DeHart DA, Owens A. The efficacy of metoclopramide in the treatment of migraine headache. Ann Emerg Med 1993 Feb;22(2):191-5. PubMed


  • Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. The Oral Sumatriptan International Multiple-Dose Study Group. Eur Neurol 1991;31(5):306-13. PubMed


  • Evers S, Frese A. Recent advances in the treatment of headaches. Curr Opin Anaesthesiol 2005 Oct;18(5):563-8. PubMed


  • Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW. Treatment of headache with botulinum toxin A--a review according to evidence-based medicine criteria. Cephalalgia 2002 Nov;22(9):699-710. [45 references] PubMed


  • Facchinetti F, Bonellie G, Kangasniemi P, Pascual J, Shuaib A. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. The Sumatriptan Menstrual Migraine Study Group. Obstet Gynecol 1995 Dec;86(6):911-6. PubMed


  • Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991 May;31(5):298-301. PubMed


  • Foley KA, Cady R, Martin V, Adelman J, Diamond M, Bell CF, Dayno JM, Hu XH. Treating early versus treating mild: timing of migraine prescription medications among patients with diagnosed migraine. Headache 2005 May;45(5):538-45. PubMed


  • Forssman B, Henriksson KG, Johannsson V, Lindvall L, Lundin H. Propranolol for migraine prophylaxis. Headache 1976 Nov;16(5):238-45. PubMed


  • Forssman B, Lindblad CJ, Zbornikova V. Atenolol for migraine prophylaxis. Headache 1983 Jul;23(4):188-90. PubMed


  • Frenken CW, Nuijten ST. Flunarizine, a new preventive approach to migraine. A double-blind comparison with placebo. Clin Neurol Neurosurg 1984;86(1):17-20. PubMed


  • Friedman AP, Di Serio FJ, Hwang DS. Symptomatic relief of migraine: multicenter comparison of Cafergot P-B, Cafergot, and placebo. Clin Ther 1989;11(1):170-82. PubMed


  • Fritsche G, Diener HC. Medication overuse headaches -- what is new. Expert Opin Drug Saf 2002 Nov;1(4):331-8. [105 references] PubMed


  • Gendolla A, Evers S. [Difficult decisions: headache treatment in pregnancy and childhood. Schmerz 2004 Oct;18(5):378-84. [8 references] PubMed


  • Gerber WD, Diener HC, Scholz E, Niederberger U. Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time- series analysis. Cephalalgia 1991 Feb;11(1):37-45. PubMed


  • Gladstone JP, Dodick DW. Current and emerging treatment options for migraine and other primary headache disorders. Expert Rev Neurother 2003;3:89-116.


  • Gobel H, Hamouz V, Hansen C, Heininger K, Hirsch S, Lindner V, Heuss D, Soyka D. Chronic tension-type headache: amitriptyline reduces clinical headache- duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain 1994 Nov;59(2):241-9. PubMed


  • Gobel H. Botulinum toxin in migraine prophylaxis. J Neurol 2004 Feb;251 Suppl :I8-11. [55 references] PubMed


  • Gomersall JD, Stuart A. Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial. J Neurol Neurosurg Psychiatry 1973 Aug;36(4):684-90. PubMed


  • Gross ML, Kay J, Turner AM, Hallett K, Cleal AL, Hassani H. Sumatriptan in acute migraine using a novel cartridge system self- injector. United Kingdom Study Group. Headache 1994 Nov-Dec;34(10):559-63. PubMed


  • Grossmann M, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int J Clin Pharmacol Ther 2000 Sep;38(9):430-5. PubMed


  • Havanka-Kanniainen H. Treatment of acute migraine attack: ibuprofen and placebo compared. Headache 1989 Sep;29(8):507-9. PubMed


  • Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24(Suppl 1):9-160. PubMed


  • Henry P, d'Allens H. Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis. French Migraine Network Bordeaux-Lyon-Grenoble. Headache 1993 Sep;33(8):432-5. PubMed


  • Hering R, Kuritzky A. Sodium valproate in the prophylactic treatment of migraine: a double- blind study versus placebo. Cephalalgia 1992 Apr;12(2):81-4. PubMed


  • Hershey AD, Powers SW, Vockell AL, LeCates S, Kabbouche M. Effectiveness of topiramate in the prevention of childhood headaches. Headache 2002 Sep;42(8):810-8. PubMed


  • Hickling EJ, Silverman DJ, Loos W. A non-pharmacological treatment of vascular headache during pregnancy. Headache 1990 Jun;30(7):407-10. PubMed


  • Hughes RC, Foster JB. BC 105 in the prophylaxis of migraine. Curr Ther Res Clin Exp 1971 Jan;13(1):63-8. PubMed


  • Hungerford GD, du Boulay GH, Zilkha KJ. Computerised axial tomography in patients with severe migraine: a preliminary report. J Neurol Neurosurg Psychiatry 1976 Oct;39(10):990-4. PubMed


  • Igarashi H, Sakai F, Kan S, Okada J, Tazaki Y. Magnetic resonance imaging of the brain in patients with migraine. Cephalalgia 1991 May;11(2):69-74. PubMed


  • Jackson NC. A comparison of oral eletriptan (UK-116.044) (20-80 mg) and oral sumatriptan (100 mg) in the acute treatment of migraine. Cephalalgia 1996;16:368-99.


  • Jensen K, Tfelt-Hansen P, Hansen EW, Krois EH, Pedersen OS. Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice. Cephalalgia 1995 Oct;15(5):423-9. PubMed


  • Jensen R, Brinck T, Olesen J. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology 1994 Apr;44(4):647-51. PubMed


  • Johannsson V, Nilsson LR, Widelius T, Javerfalk T, Hellman P, Akesson JA, Olerud B, Gustafsson CL, Raak A, Sandahl G, et al.. Atenolol in migraine prophylaxis a double-blind cross-over multicentre study. Headache 1987 Jul;27(7):372-4. PubMed


  • Johnson ES, Ratcliffe DM, Wilkinson M. Naproxen sodium in the treatment of migraine. Cephalalgia 1985 Mar;5(1):5-10. PubMed


  • Johnson RH, Hornabrook RW, Lambie DG. Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis. Acta Neurol Scand 1986 May;73(5):490-2. PubMed


  • Jones J, Pack S, Chun E. Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Am J Emerg Med 1996 May;14(3):262-4. PubMed


  • Kangasniemi P, Andersen AR, Andersson PG, Gilhus NE, Hedman C, Hultgren M, Vilming S, Olesen J. Classic migraine: effective prophylaxis with metoprolol. Cephalalgia 1987 Dec;7(4):231-8. PubMed


  • Kangasniemi P, Hedman C. Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study. Cephalalgia 1984 Jun;4(2):91-6. PubMed


  • Kangasniemi P, Kaaja R. Ketoprofen and ergotamine in acute migraine. J Intern Med 1992 May;231(5):551-4. PubMed


  • Kaniecki R. Intercepting migraine: results of early therapy with nonspecific and migraine-specific agents. Curr Treat Options Neurol 2006 Jan;8(1):3-10. PubMed


  • Klapper J. Divalproex sodium in migraine prophylaxis: a dose-controlled study [published erratum appears in Cephalalgia 1997 Nov;17(7):798]. Cephalalgia 1997 Apr;17(2):103-8. PubMed


  • Klassen A, Elkind A, Asgharnejad M, Webster C, Laurenza A. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group. Headache 1997 Nov-Dec;37(10):640-5. PubMed


  • Kloster R, Nestvold K, Vilming ST. A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia 1992 Jun;12(3):169-71; discussion 128. [9 references] PubMed


  • Krakowski AJ, Engisch R. A new agent for chemotherapy of migraine headaches: a controlled study. Psychosomatics 1973 Sep-Oct;14(5):302-8. PubMed


  • Kubitzek F, Ziegler G, Gold MS, Liu JM, Ionescu E. Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain 2003;7(2):155-62. PubMed


  • Kuhn MJ, Shekar PC. A comparative study of magnetic resonance imaging and computed tomography in the evaluation of migraine. Comput Med Imaging Graph 1990 Mar-Apr;14(2):149-52. PubMed


  • Lance JW, Anthony M. Clinical trial of a new serotonin antagonist, BC105, in the prevention of migraine. Med J Aust 1968 Jan 13;1(2):54-5. PubMed


  • Lance JW, Curran DA. Treatment of chronic tension headache. Lancet 1964 Jun 6;1:1236-9. PubMed


  • Langemark M, Olesen J. Effervescent ASA versus solid ASA in the treatment of tension headache. A double-blind, placebo controlled study. Headache 1987 Feb;27(2):90-5. PubMed


  • Lawrence ER, Hossain M, Littlestone W. Sanomigran for migraine prophylaxis, controlled multicenter trial in general practice. Headache 1977 Jul;17(3):109-12. PubMed


  • Lewis DW, Diamond S, Scott D, Jones V. Prophylactic treatment of pediatric migraine. Headache 2004 Mar;44(3):230-7. PubMed


  • Lewis DW, Scott D, Rendin V. Treatment of paediatric headache. Expert Opin Pharmacother 2002 Oct;3(10):1433-42. [37 references] PubMed


  • Lewis DW, Yonker M, Winner P, Sowell M. The treatment of pediatric migraine. Pediatr Ann 2005 Jun;34(6):448-60. [52 references] PubMed


  • Lindegaard KF, Ovrelid L, Sjaastad O. Naproxen in the prevention of migraine attacks. A double-blind placebo-controlled cross-over study. Headache 1980 Mar;20(2):96-8. PubMed


  • Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, Harrison W, ID Migraine validation study. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology 2003 Aug 12;61(3):375-82. PubMed


  • Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology 2004 Dec 28;63(12):2240-4. PubMed


  • Lipton RB, Stewart WF, Sawyer J. Stratified care is a more effective strategy than stepped care: results of a randomized clinical trial. Neurology 2000;54(Suppl 3):A14.


  • Louis P. A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine. Headache 1981 Nov;21(6):235-9. PubMed


  • Macgregor EA, Hackshaw A. Prevention of migraine in the pill-free interval of combined oral contraceptives: a double-blind, placebo-controlled pilot study using natural oestrogen supplements. J Fam Plann Reprod Health Care 2002 Jan;28(1):27-31. PubMed


  • Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache 2004 Oct;44(9):885-90. PubMed


  • Marcus DA, Scharff L, Turk DC. Nonpharmacological management of headaches during pregnancy. Psychosom Med 1995 Nov-Dec;57(6):527-35. PubMed


  • Marcus DA. Headache in pregnancy. Curr Pain Headache Rep 2003 Aug;7(4):288-96. [119 references] PubMed


  • Markley HG, Cheronis JC, Piepho RW. Verapamil in prophylactic therapy of migraine. Neurology 1984 Jul;34(7):973-6. PubMed


  • Martinez-Martin P, Raffaelli E Jr, Titus F, Despuig J, Fragoso YD, Diez-Tejedor E, Liano H, Leira R, Cornet ME, van Toor BS, Camara J, Peil H, Vix JM, Ortiz P. Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre study. Cephalalgia 2001 Jun;21(5):604-10. PubMed


  • Mathew NT, Dexter J, Couch J, Flamenbaum W, Goldstein J, Rapoport A, Sheftell F, Saper J, Silberstein S, Solomon S, et al. Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group. Arch Neurol 1992 Dec;49(12):1271-6. [27 references] PubMed


  • Mathew NT, Naratriptan S2WA3003 Study Group, Asgharnejad M, Peykamian M, Laurenza A. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. Neurology 1997 Dec;49(6):1485-90. PubMed


  • Mathew NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadan N, Stacey B, Tepper S. Efficacy of gabapentin in migraine prophylaxis. Headache 2001 Feb;41(2):119-28. PubMed


  • Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, Rapoport AM, Silber CJ, Deaton RL. Migraine prophylaxis with divalproex . Arch Neurol 1995 Mar;52(3):281-6. PubMed


  • Mathew NT. Amelioration of ergotamine withdrawal symptoms with naproxen. Headache 1987 Mar;27(3):130-3. PubMed


  • Mehlisch DR, Weaver M, Fladung B. Ketoprofen, acetaminophen, and placebo in the treatment of tension headache. Headache 1998 Sep;38(8):579-89. PubMed


  • Mei D, Capuano A, Vollono C, Evangelista M, Ferraro D, Tonali P, Di Trapani G. Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study. Neurol Sci 2004 Dec;25(5):245-50. PubMed


  • Melchart D, Linde K, Berman B, White A, Vickers A, Allais G, Brinkhaus B. Acupuncture for idiopathic headache (review). Cochrane Database Syst Rev 2001;(1):CD001218.


  • Mendenopoulos G, Manafi T, Logothetis I, Bostantjopoulou S. Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation. Cephalalgia 1985 Mar;5(1):31-7. PubMed


  • Migliardi JR, Armellino JJ, Friedman M, Gillings DB, Beaver WT. Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther 1994 Nov;56(5):576-86. PubMed


  • Mikkelsen B, Pedersen KK, Christiansen LV. Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo. Acta Neurol Scand 1986 Apr;73(4):423-7. PubMed


  • Miller DS, Talbot CA, Simpson W, Korey A. A comparison of naproxen sodium, acetaminophen and placebo in the treatment of muscle contraction headache. Headache 1987 Jul;27(7):392-6. PubMed


  • Miller GS. Efficacy and safety of levetiracetam in pediatric migraine. Headache 2004 Mar;44(3):238-43. PubMed


  • Murphy JJ, Heptinstall S, Mitchell JR. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988 Jul 23;2(8604):189-92. PubMed


  • Myllyla VV, Havanka H, Herrala L, Kangasniemi P, Rautakorpi I, Turkka J, Vapaatalo H, Eskerod O. Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study. Headache 1998 Mar;38(3):201-7. PubMed


  • Nappi G, Sicuteri F, Byrne M, Roncolato M, Zerbini O. Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol 1994 Jan;241(3):138-44. PubMed


  • Nebe J, Heier M, Diener HC. Low-dose ibuprofen in self-medication of mild to moderate headache: a comparison with acetylsalicylic acid and placebo. Cephalalgia 1995 Dec;15(6):531-5. PubMed


  • Newman L, Mannix LK, Landy S, Silberstein S, Lipton RB, Putnam DG, Watson C, Jobsis M, Batenhorst A, O'Quinn S. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache 2001 Mar;41(3):248-56. PubMed


  • Olsson JE, Behring HC, Forssman B, Hedman C, Hedman G, Johansson F, Kinnman J, Palhagen SE, Samuelsson M, Strandman E. Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study. Acta Neurol Scand 1984 Sep;70(3):160-8. PubMed


  • Osborn RE, Alder DC, Mitchell CS. MR imaging of the brain in patients with migraine headaches. AJNR Am J Neuroradiol 1991 May-Jun;12(3):521-4. PubMed


  • Osterman PO. A comparison between placebo, pizotifen and 1-isopropyl-3-hydroxy-5-semicarbazono-6-oxo-2.3.5.6-tetrahydroindol (Divascan) in migraine prophylaxis. Acta Neurol Scand 1977 Jul;56(1):17-28. PubMed


  • Ostfeld AM. A study of migraine pharmacotherapy. Am J Med Sci 1961 Feb;241:192-8. PubMed


  • Ozyalcin SN, Talu GK, Kiziltan E, Yucel B, Ertas M, Disci R. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 2005 Feb;45(2):144-52. PubMed


  • Packman B, Packman E, Doyle G, Cooper S, Ashraf E, Koronkiewicz K, Jayawardena S. Solubilized ibuprofen: evaluation of onset, relief, and safety of a novel formulation in the treatment of episodic tension-type headache. Headache 2000 Jul-Aug;40(7):561-7. PubMed


  • Pakalnis A, Greenberg G, Drake ME Jr, Paolichi J. Pediatric migraine prophylaxis with divalproex. J Child Neurol 2001 Oct;16(10):731-4. PubMed


  • Palevitch D, Earon G, Carasso R. Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytother Res 1997;11:508-11.


  • Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996 Jun;16(4):257-63. PubMed


  • Peters BH, Fraim CJ, Masel BE. Comparison of 650 mg aspirin and 1,000 mg acetaminophen with each other, and with placebo in moderately severe headache. Am J Med 1983 Jun 14;74(6A):36-42. PubMed


  • Pfaffenrath V, Cunin G, Sjonell G, Prendergast S. Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan. Headache 1998 Mar;38(3):184-90. PubMed


  • Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH, Investigators. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia 2002 Sep;22(7):523-32. PubMed


  • Pfaffenrath V, Rehm M. Migraine in pregnancy: what are the safest treatment options. Drug Saf 1998 Nov;19(5):383-8. [52 references] PubMed


  • Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, Taneri Z, Soyka D, Gobel H, Fischer M. Magnesium in the prophylaxis of migraine--a double-blind placebo- controlled study. Cephalalgia 1996 Oct;16(6):436-40. PubMed


  • Pini LA, Ferrari A, Guidetti G, Galetti G, Sternieri E. Influence of flunarizine on the altered electronystagmographic (ENG) recordings in migraine. Cephalalgia 1985 May;5 Suppl 2:173-5. PubMed


  • Pini LA, Sternieri E, Fabbri L, Zerbini O, Bamfi F. High efficacy and low frequency of headache recurrence after oral sumatriptan. The Oral Sumatriptan Italian Study Group [published erratum appears in J Int Med Res 1995 Jul-Aug;23(4):315]. J Int Med Res 1995 Mar-Apr;23(2):96-105. PubMed


  • Pita E, Higueras A, Bolanos J, Perez N, Mundo A. Propranolol and migraine. A clinical trial. Arch Farmacol Toxicol 1977 Dec;3(3):273-8. PubMed


  • Pradalier A, Serratrice G, Collard M, Hirsch E, Feve J, Masson M, Masson C, Dry J, Koulikovsky G, Nguyen G, et al.. Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study. Cephalalgia 1989 Dec;9(4):247-53. PubMed


  • Prior MJ, Cooper KM, May LG, Bowen DL. Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, double-blind, placebo-controlled trial. Cephalalgia 2002 Nov;22(9):740-8. PubMed


  • Rapoport AM, Bigal ME. ID-migraine. Neurol Sci 2004 Oct;25 Suppl 3:S258-60. PubMed


  • Rapoport AM, Ramadan NM, Adelman JU, Mathew NT, Elkind AH, Kudrow DB, Earl NL. Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group . Neurology 1997 Nov;49(5):1210-8. PubMed


  • Robbins L, Friedman H. MRI in migraineurs. Headache 1992 Nov;32(10):507-8. PubMed


  • Rowan AB, Andrasik F. Efficacy and cost-effectiveness of minimal therapist contact treatments of chronic headache: a review. Behav Ther 1996;27:207-34.


  • Rozen TD. Aborting a prolonged migrainous aura with intravenous prochlorperazine and magnesium sulfate. Headache 2003 Sep;43(8):901-3. PubMed


  • Russell MB, Holm-Thomsen OE, Rishoj Nielsen M, Cleal A, Pilgrim AJ, Olesen J. A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice. Cephalalgia 1994 Aug;14(4):291-6. PubMed


  • Ryan RE. BC-105 a new preparation for the interval treatment of migraine--a double blind evaluation compared with a placebo. Headache 1971 Apr;11(1):6-18. PubMed


  • Ryan RE. Double-blind clinical evaluation of the efficacy and safety of ergostine-caffeine, ergotamine-caffeine, and placebo in migraine headache. Headache 1970 Jan;9(4):212-20. PubMed


  • Ryan RE. Double-blind crossover comparison of bc-105, methysergide and placebo in the prophylaxis of migraine headache. Headache 1968 Oct;8(3):118-26. PubMed


  • Ryan RE. Motrin--a new agent for the symptomatic treatment of muscle contraction headache. Headache 1977 Jan;16(6):280-3. PubMed


  • Sadovsky R, Dodick DW. Identifying migraine in primary care settings. Am J Med 2005 Mar;118 Suppl :11S-17S. [36 references] PubMed


  • Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 1990 Nov;30(11):705-9. PubMed


  • Sandor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005 Feb 22;64(4):713-5. PubMed


  • Sargent J, Kirchner JR, Davis R, Kirkhart B. Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study. Neurology 1995 Aug;45(8 Suppl 7):S10-4. PubMed


  • Sargent J, Solbach P, Damasio H, Baumel B, Corbett J, Eisner L, Jessen B, Kudrow L, Mathew N, Medina J, et al.. A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache. Headache 1985 Sep;25(6):320-4. PubMed


  • Sargent JD, Baumel B, Peters K, Diamond S, Saper JR, Eisner LS, Solbach P. Aborting a migraine attack: naproxen sodium v ergotamine plus caffeine. Headache 1988 May;28(4):263-6. PubMed


  • Sargent JD, Lawson RC, Solbach P, Coyne L. Use of CT scans in an out-patient headache population: an evaluation. Headache 1979 Nov;19(7):388-90. PubMed


  • Schachtel BP, Furey SA, Thoden WR. Nonprescription ibuprofen and acetaminophen in the treatment of tension- type headache. J Clin Pharmacol 1996 Dec;36(12):1120-5. PubMed


  • Schachtel BP, Thoden WR, Konerman JP, Brown A, Chaing DS. Headache pain model for assessing and comparing the efficacy of over-the-counter analgesic agents. Clin Pharmacol Ther 1991 Sep;50(3):322-9. PubMed


  • Schachtel BP, Thoden WR. Onset of action of ibuprofen in the treatment of muscle-contraction headache. Headache 1988 Aug;28(7):471-4. PubMed


  • Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial . Neurology 1998 Feb;50(2):466-70. PubMed


  • Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 1994 Oct;14(5):328-9. PubMed


  • Schrader H, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ 2001 Jan 6;322(7277):19-22. PubMed


  • Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group. Eur Neurol 1991;31(5):323-31. PubMed


  • Serdaroglu G, Erhan E, Tekgul H, Oksel F, Erermis S, Uyar M, Tutuncuoglu S. Sodium valproate prophylaxis in childhood migraine. Headache 2002 Sep;42(8):819-22. PubMed


  • Silberstein S, Mathew N, Saper J, Jenkins S, BOTOX Migraine Clinical Research Group. Botulinum toxin type A as a migraine preventive treatment. Headache 2000 Jun;40(6):445-50. PubMed


  • Silberstein SD, Lipton RB. Chronic daily headache. In: Goadsby PJ, Silberstein SD, editor(s). Blue books of practical neurology: headache. Boston (MA): Butterworth-Heinemann; 1997. p. 201-25.


  • Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004 Apr;61(4):490-5. PubMed


  • Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Steiner TJ, International Headache Society. The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 medication-overuse headache. Cephalalgia 2005 Jun;25(6):460-5. PubMed


  • Silberstein SD, Rosenberg J. Multispecialty consensus on diagnosis and treatment of headache. Neurology 2000 Apr 25;54(8):1553. PubMed


  • Silberstein SD. Headaches in pregnancy. Neurol Clin 2004 Nov;22(4):727-56. [88 references] PubMed


  • Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000 Sep 26;55(6):754-62. [14 references] PubMed


  • Sjaastad O, Stensrud P. Appraisal of BC-105 in migraine prophylaxis. Acta Neurol Scand 1969;45(5):594-600. PubMed


  • Solomon GD, Cady RK, Klapper JA, Earl NL, Saper JR, Ramadan NM. Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group. Neurology 1997 Nov;49(5):1219-25. PubMed


  • Solomon GD, Steel JG, Spaccavento LJ. Verapamil prophylaxis of migraine. A double-blind, placebo-controlled study. JAMA 1983 Nov 11;250(18):2500-2. PubMed


  • Solomon GD. Verapamil and propranolol in migraine prophylaxis: a double-blind crossover study. Headache 1986;26:325.


  • Sorensen PS, Hansen K, Olesen J. A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine. Cephalalgia 1986 Mar;6(1):7-14. PubMed


  • Stark R, Dahlof C, Haughie S, Hettiarachchi J, Eletriptan Steering Committee. Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacks. Cephalalgia 2002 Feb;22(1):23-32. PubMed


  • Steiner TJ, Ahmed F, Findley LJ, MacGregor EA, Wilkinson M. S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study. Cephalalgia 1998 Jun;18(5):283-6. PubMed


  • Steiner TJ, Joseph R, Hedman C, Rose FC. Metoprolol in the prophylaxis of migraine: parallel-groups comparison with placebo and dose-ranging follow-up. Headache 1988 Feb;28(1):15-23. PubMed


  • Steiner TJ, Lange R, Voelker M. Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 2003 Feb;23(1):59-66. PubMed


  • Steiner TJ, Lange R. Ketoprofen (25 mg) in the symptomatic treatment of episodic tension- type headache: double-blind placebo-controlled comparison with acetaminophen (1000 mg). Cephalalgia 1998 Jan;18(1):38-43. PubMed


  • Stensrud P, Sjaastad O. Short-term clinical trial of phopranolol in racemic form (Inderal), D-propranolol and placebo in migraine. Acta Neurol Scand 1976 Mar;53(3):229-32. PubMed


  • Storey JR, Calder CS, Hart DE, Potter DL. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache 2001 Nov-Dec;41(10):968-75. PubMed


  • Straumsheim P, Borchgrevink C, Mowinckel P, Kierulf H, Hafslund O. Homeopathic treatment of migraine: a double blind, placebo controlled trial of 68 patients [see comment. Br Homeopath J 2000 Jan;89(1):4-7. PubMed


  • Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose- Defining Study Group. Eur Neurol 1991;31(5):300-5. PubMed


  • Symon DN, Russell G. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine . Arch Dis Child 1995 Jan;72(1):48-50. PubMed


  • Szekely B, Merryman S, Croft H, Post G. Prophylactic effects of naproxen sodium on perimenstrual headache: a double-blind, placebo-controlled study. Cephalalgia 1989;9(Suppl 10):452-3.


  • Takiya L, Piccininni LC, Kamath V. Safety and efficacy of eletriptan in the treatment of acute migraine. Pharmacotherapy 2006 Jan;26(1):115-28. [46 references] PubMed


  • Tek DS, McClellan DS, Olshaker JS, Allen CL, Arthur DC. A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med 1990 Oct;19(10):1083-7. PubMed


  • Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 1995 Oct 7;346(8980):923-6. PubMed


  • Tfelt-Hansen P, Olesen J, Aebelholt-Krabbe A, Melgaard B, Veilis B. A double blind study of metoclopramide in the treatment of migraine attacks. J Neurol Neurosurg Psychiatry 1980 Apr;43(4):369-71. PubMed


  • Tfelt-Hansen P, Olesen J. Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia 1984 Jun;4(2):107-11. PubMed


  • Tfelt-Hansen P, Standnes B, Kangasneimi P, Hakkarainen H, Olesen J. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand 1984 Jan;69(1):1-8. PubMed


  • Tfelt-Hansen P, Welch KM. General principles of pharmacologic treatment. In: Oleson J, Tfelt-Hansen P, Welch KM, editor(s). The headaches. New York (NY): Raven Press; 1993. p. 299-303.


  • Thomas M, Behari M, Ahuja GK. Flunarizine in migraine prophylaxis: an Indian trial. Headache 1991 Oct;31(9):613-5. PubMed


  • Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group . N Engl J Med 1991 Aug 1;325(5):316-21. PubMed


  • Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 2003 Jan 1;289(1):65-9. PubMed


  • van de Ven LL, Franke CL, Koehler PJ. Prophylactic treatment of migraine with bisoprolol: a placebo- controlled study. Cephalalgia 1997 Aug;17(5):596-9. PubMed


  • van Gerven JM, Schoemaker RC, Jacobs LD, Reints A, Ouwersloot-van der Meij MJ, Hoedemaker HG, Cohen AF. Self-medication of a single headache episode with ketoprofen, ibuprofen or placebo, home-monitored with an electronic patient diary. Br J Clin Pharmacol 1996 Oct;42(4):475-81. PubMed


  • Victor S, Ryan SW. Drugs for preventing migraine headaches in children. Cochrane Database Syst Rev 2003;(4):CD002761. [45 references] PubMed


  • Visser WH, Klein KB, Cox RC, Jones D, Ferrari MD. 311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo- controlled, dose-range finding study. Neurology 1996 Feb;46(2):522-6. PubMed


  • von Graffenried B, Nuesch E. Non-migrainous headache for the evaluation of oral analgesics. Br J Clin Pharmacol 1980 Oct;10 Suppl 2:225S-231S. PubMed


  • Waelkens J. Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia 1984 Jun;4(2):85-90. PubMed


  • Waters WE. A randomized controlled trial of ergotamine tartrate. Br J Prev Soc Med 1970 Feb;24(1):65. PubMed


  • Welch KM, Ellis DJ, Keenan PA. Successful migraine prophylaxis with naproxen sodium. Neurology 1985 Sep;35(9):1304-10. PubMed


  • Whitmarsh TE, Coleston-Shields DM, Steiner TJ. Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine. Cephalalgia 1997 Aug;17(5):600-4. PubMed


  • Wideroe TE, Vigander T. Propranolol in the treatment of migraine. Br Med J 1974 Jun 29;2(5921):699-701. PubMed


  • Ziegler DK, Ellis DJ. Naproxen in prophylaxis of migraine. Arch Neurol 1985 Jun;42(6):582-4. PubMed


  • Ziegler DK, Hurwitz A, Hassanein RS, Kodanaz HA, Preskorn SH, Mason J. Migraine prophylaxis. A comparison of propranolol and amitriptyline. Arch Neurol 1987 May;44(5):486-9. PubMed


© 1998-2009 National Guideline Clearinghouse

Date Modified: 2/9/2009

 

 

   
DHHS Logo